Curis
CRIS
#11024
Rank
NZ$1.16 M
Marketcap
NZ$0.60
Share price
-17.89%
Change (1 day)
-80.25%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): NZ-$40.19

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$41.01. In 2025 the company made an earnings per share (EPS) of NZ-$41.01 an increase over its 2024 EPS that were of NZ-$242.28.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$40.19-2.01%
2025NZ-$41.01-83.07%
2024NZ-$242.28-22.15%
2023NZ-$311.21-26.17%
2022NZ-$421.4922.3%
2021NZ-$344.64-25.37%
2020NZ-$461.82-30.93%
2019NZ-$668.60-2.02%
2018NZ-$682.39
2016NZ-$1,551-10%
2015NZ-$1,723138.1%
2014NZ-$723.7440%
2013NZ-$516.96-25%
2012NZ-$689.2866.67%
2011NZ-$413.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.26-105.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.13-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.62-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$5.39-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.34-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$8.68-78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ-$0.29-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA